GURUFOCUS.COM » STOCK LIST » Technology » Software » Research Solutions Inc (FRA:61I) » Definitions » Cash And Cash Equivalents

Research Solutions (FRA:61I) Cash And Cash Equivalents : €3.88 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Research Solutions Cash And Cash Equivalents?

Research Solutions's quarterly cash and cash equivalents declined from Sep. 2023 (€9.26 Mil) to Dec. 2023 (€2.47 Mil) but then increased from Dec. 2023 (€2.47 Mil) to Mar. 2024 (€3.88 Mil).

Research Solutions's annual cash and cash equivalents increased from Jun. 2021 (€9.13 Mil) to Jun. 2022 (€10.03 Mil) and increased from Jun. 2022 (€10.03 Mil) to Jun. 2023 (€12.50 Mil).


Research Solutions Cash And Cash Equivalents Historical Data

The historical data trend for Research Solutions's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Research Solutions Cash And Cash Equivalents Chart

Research Solutions Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.74 8.27 9.13 10.03 12.50

Research Solutions Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.33 12.50 9.26 2.47 3.88

Research Solutions Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Research Solutions  (FRA:61I) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Research Solutions Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Research Solutions's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Research Solutions (FRA:61I) Business Description

Traded in Other Exchanges
Address
10624 S. Eastern Avenue, Suite A-614, Henderson, NV, USA, 89052
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.

Research Solutions (FRA:61I) Headlines

No Headlines